Please assess the completion status of the following clinical trial:

Trial Title: Spironolactone in Diabetic Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diabetes Mellitus~* Diabetic Nephropathy~* Glomerular filtration rate \> 30 ml/min/1.73 m2~* Blood pressure \> 130/80 mm Hg~Exclusion Criteria:~* Child bearing potential~* Plasma-potassium \>4.5 mmol/l~* Breastfeeding~* Abuse of alcohol or drugs~* Non-diabetic kidney disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).